These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28767734)

  • 61. Health-related quality of life and glycaemic control among adults with type 1 and type 2 diabetes - a nationwide cross-sectional study.
    Svedbo Engström M; Leksell J; Johansson UB; Borg S; Palaszewski B; Franzén S; Gudbjörnsdottir S; Eeg-Olofsson K
    Health Qual Life Outcomes; 2019 Aug; 17(1):141. PubMed ID: 31412881
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mealtime insulin bolus adherence and glycemic control in adolescents on insulin pump therapy.
    Spaans E; van Hateren KJJ; Groenier KH; Bilo HJG; Kleefstra N; Brand PLP
    Eur J Pediatr; 2018 Dec; 177(12):1831-1836. PubMed ID: 30238153
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.
    Dejgaard TF; Frandsen CS; Hansen TS; Almdal T; Urhammer S; Pedersen-Bjergaard U; Jensen T; Jensen AK; Holst JJ; Tarnow L; Knop FK; Madsbad S; Andersen HU
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):221-232. PubMed ID: 26656289
    [TBL] [Abstract][Full Text] [Related]  

  • 64. How Much Do We Know about the Biopsychosocial Predictors of Glycaemic Control? Age and Clinical Factors Predict Glycaemic Control, but Psychological Factors Do Not.
    Abdullah MFILB; Sidi H; Ravindran A; Gosse PJ; Kaunismaa ES; Mainland RL; Mustafa N; Hatta NH; Arnawati P; Zulkifli AY; Woon LS
    J Diabetes Res; 2020; 2020():2654208. PubMed ID: 32455131
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysis.
    Whyte MB; Hinton W; McGovern A; van Vlymen J; Ferreira F; Calderara S; Mount J; Munro N; de Lusignan S
    PLoS Med; 2019 Oct; 16(10):e1002942. PubMed ID: 31589609
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Predictors of poor glycaemic control during the initial five years post-diagnosis in rural adults with type 2 diabetes.
    Kellow NJ; Savige GS; Khalil H
    Aust J Rural Health; 2011 Oct; 19(5):267-74. PubMed ID: 21933370
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lack of synergism between long-term poor glycaemic control and three gene polymorphisms of the renin angiotensin system on risk of developing diabetic nephropathy in type I diabetic patients.
    Tarnow L; Kjeld T; Knudsen E; Major-Pedersen A; Parving HH
    Diabetologia; 2000 Jun; 43(6):794-9. PubMed ID: 10907125
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Translating glycated hemoglobin A1c into time spent in glucose target range: A multicenter study.
    Petersson J; Åkesson K; Sundberg F; Särnblad S
    Pediatr Diabetes; 2019 May; 20(3):339-344. PubMed ID: 30652407
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Albuminuria and low bone mineral density in paediatric patients with type 1 diabetes.
    Souza KSC; Gomes IS; Oliveira YMDC; Loureiro MB; Silva HPVD; Melo TR; Santos MGD; Bortolin RH; Maciel Neto JJ; Arrais RF; Almeida MDG; Ururahy MAG; Rezende AA
    J Paediatr Child Health; 2019 Apr; 55(4):411-415. PubMed ID: 30218466
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intermediate hyperglycaemia to predict progression to type 2 diabetes (ELSA-Brasil): an occupational cohort study in Brazil.
    Schmidt MI; Bracco PA; Yudkin JS; Bensenor IM; Griep RH; Barreto SM; Castilhos CD; Duncan BB
    Lancet Diabetes Endocrinol; 2019 Apr; 7(4):267-277. PubMed ID: 30803929
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The association between sociodemographic and clinical characteristics and poor glycaemic control: a longitudinal cohort study.
    McBrien KA; Manns BJ; Hemmelgarn BR; Weaver R; Edwards AL; Ivers N; Rabi D; Lewanczuk R; Braun T; Naugler C; Campbell D; Saad N; Tonelli M
    Diabet Med; 2016 Nov; 33(11):1499-1507. PubMed ID: 26526088
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Changes in HbA1c and frequency of measuring HbA1c and adjusting glucose-lowering medications in the 10 years following diagnosis of type 2 diabetes: a population-based study in the UK.
    Lind M; Pivodic A; Cea-Soriano L; Nerman O; Pehrsson NG; Garcia-Rodriguez LA
    Diabetologia; 2014 Aug; 57(8):1586-94. PubMed ID: 24811709
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A cross-sectional study of glycaemic control, complications and psychosocial functioning among 18- to 35-year-old adults with type 1 diabetes.
    Zoffmann V; Vistisen D; Due-Christensen M
    Diabet Med; 2014 Apr; 31(4):493-9. PubMed ID: 24236961
    [TBL] [Abstract][Full Text] [Related]  

  • 74. HbA1c and the Prediction of Type 2 Diabetes in Children and Adults.
    Vijayakumar P; Nelson RG; Hanson RL; Knowler WC; Sinha M
    Diabetes Care; 2017 Jan; 40(1):16-21. PubMed ID: 27810987
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Addition of intermittently scanned continuous glucose monitoring to standard care in a cohort of pregnant women with type 1 diabetes: effect on glycaemic control and pregnancy outcomes.
    Perea V; Picón MJ; Megia A; Goya M; Wägner AM; Vega B; Seguí N; Montañez MD; Vinagre I
    Diabetologia; 2022 Aug; 65(8):1302-1314. PubMed ID: 35546211
    [TBL] [Abstract][Full Text] [Related]  

  • 76. HbA
    Lind M; Pivodic A; Svensson AM; Ólafsdóttir AF; Wedel H; Ludvigsson J
    BMJ; 2019 Aug; 366():l4894. PubMed ID: 31462492
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Influence of age at diagnosis on glycaemic control evolution in patients with type 1 diabetes.
    Forga L; Goñi MJ; Cambra K; Ibáñez B; Mozas D; Chueca M
    Diabetes Metab; 2013 Dec; 39(6):519-23. PubMed ID: 23871433
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.
    Moy FM; Ray A; Buckley BS; West HM
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD009613. PubMed ID: 28602020
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial.
    Tauschmann M; Thabit H; Bally L; Allen JM; Hartnell S; Wilinska ME; Ruan Y; Sibayan J; Kollman C; Cheng P; Beck RW; Acerini CL; Evans ML; Dunger DB; Elleri D; Campbell F; Bergenstal RM; Criego A; Shah VN; Leelarathna L; Hovorka R;
    Lancet; 2018 Oct; 392(10155):1321-1329. PubMed ID: 30292578
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Initiation of insulin pump therapy in children at diagnosis of type 1 diabetes resulted in improved long-term glycemic control.
    Lang EG; King BR; Miller MN; Dunn SV; Price DA; Foskett DC
    Pediatr Diabetes; 2017 Feb; 18(1):26-32. PubMed ID: 26782779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.